Treatment of cognitive impairment in Alzheimer's disease

Australian Journal of Hospital Pharmacy

Volumn 28, Issue 4, 1998, Pages 261-266

  Byrne, Gerard J A ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DONEPEZIL; GALANTAMINE; MELAMELINE; METRIFONATE; MUSCARINIC AGENT; RIVASTIGMINE; SABCOMELINE; TACRINE; UNCLASSIFIED DRUG; VELNACRINE;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DRUG CHOICE; DRUG EFFICACY; HUMAN; REVIEW; TREATMENT PLANNING;

EID: 0031814549     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr1998284261     Document Type: Review

References (2)

1. Alzheimcr A. About a peculiar disease of the cerebral cortex (1907). Translated by Jarvik L, Greenson H. Alzheimer Dis Assoc Disord 1987; 1: 7-8.
2. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76: 465-79.